November 22, 2024

DKFZ: Twelve scientists ranking in the top 1%

DKFZ: Twelve scientists ranking in the top 1%

Twelve scientists who conduct research at the German Cancer Research Center (DKFZ) or head joint bridge departments with the DKFZ have made it to the top in 2024: they are among the leading one percent of the world’s most cited researchers in their respective fields. Scientists whose work is particularly frequently cited by peers are considered to have above-average recognition in their field. Therefore, citation frequency is one of the important metrics for measuring the influence and performance of individual researchers.

The “Web of Science Group” of the US company Clarivate annually publishes a ranking of the world’s most cited scientists in 20 different fields, covering all of science, medicine, economics and social sciences, as well as in the “Cross Fields” category.

In 2024, 6886 researchers worldwide are among the top one percent of most cited experts in their respective fields. This year, eleven scientists who conduct research at the DKFZ are among the 332 researchers from German institutions who are ranked in the top one percent – as heads of scientific departments or of bridge units with university medicine or other research institutions.

The top ranked DKFZ scientists in 2024 are:

  • Ralf Bartenschlager (DKFZ and Heidelberg University Hospital, UKHD) has paved the way for the development of effective drugs against the dangerous hepatitis C virus with his groundbreaking research results.
  • The epidemiologist Hermann Brenner (DKFZ and NCT Heidelberg) is considered a leading expert in the evaluation of colorectal cancer prevention measures. He was recently identified by Laborjournal as the most cited German researcher in the field of oncology.
  • Eran Elinav is an expert on the health effects of the gut microbiome. He works at the Weizmann Institute in Israel and heads a research department at the DKFZ that focuses on the influence of the microbiome on carcinogenesis.
  • Biochemist Tobias Dick is investigating how (cancer) cells deal with oxidative stress.
  • Andreas von Deimling is internationally known for developing diagnostic antibodies that can be used to detect cancer-specific mutations and that are used worldwide to better assess brain tumors. He heads a clinical cooperation unit of the DKFZ and the UKHD.
  • Nuclear medicine specialist Uwe Haberkorn, who also heads a clinical cooperation unit of the DKFZ and the UKHD, is establishing new nuclear medicine procedures based on peptides and antibodies. He is Medical Director of Nuclear Medicine at the UKHD.
  • Mathias Heikenwälder (University of Tübingen and DKFZ) is investigating how chronic inflammation causes cancer and how these processes can be stopped.
  • Neurologist Michael Platten heads a clinical cooperation unit of the DKFZ and the University Medical Center Mannheim. He is medical director of the Neurological University Hospital Mannheim and is researching immunotherapies for brain tumors.
  • Oncologist Andreas Schneeweiß (NCT Heidelberg and DKFZ) is investigating molecular tumor profiles to better treat breast cancer patients.
  • Oliver Stegle (DKFZ and EMBL) develops methods for the analysis of high-throughput data. One focus here is on methods for studying genetic variations in individual cells.
  • Immunologist Uğur Şahin (University and University Medical Center of Mainz) heads the Department of mRNA-based Cancer Therapies at the Helmholtz Institute HI-TRON in Mainz. HI-TRON Mainz is a cooperative project involving the DKFZ, TRON gGmbH, the University Medical Center and the University of Mainz.
  • Neurologist Wolfgang Wick is investigating molecular targets for possible targeted therapies for brain tumors. He heads a clinical cooperation unit of the DKFZ and the UKHD and is medical director of the Department of Neurology at Heidelberg University Hospital.

For the current list, Clarivate considered the authors of all scientific publications that appeared between 2013 and 2023 and that were among the one percent of most-cited papers at the end of 2023.

Depending on the size of the field, a differing number of citations is required to make it into the top one percent. Most of the researchers ranked come from US institutions (36.4%), followed by China (20.4%), the UK (8.2%) and Germany (4.8%).

Our latest News

discover more
Brain tumour cells rapidly integrate into brain-wide neuronal circuits

Brain tumour cells rapidly integrate into brain-wide neuronal circuits

Researchers at the Medical Faculty of Heidelberg University and the Heidelberg University Hospital have used modified rabies viruses to label glioblastoma tumour cells and their direct cell contacts in the mouse brain. The new method showed that the tumour cells are connected to different types of nerve cells throughout the entire brain at a very […]

Warm – warmer – neuronal rapid fire: How the brain gets used to heat

Warm – warmer – neuronal rapid fire: How the brain gets used to heat

For the first time, researchers from the Heidelberg Medical Faculty of the Heidelberg University describe a cell-specific neuronal mechanism associated with heat tolerance in the journal Nature Neuroscience. Animals and humans develop a certain tolerance to prolonged heat: the body adjusts to release heat instead of generating it, and the metabolism and cardiovascular system adapt. […]

EMBL Agri-Tech Partnership to deliver safe food and environmental health

EMBL Agri-Tech Partnership to deliver safe food and environmental health

The partnership will address global food security challenges through optimised agricultural research and data-driven innovation ByEffie Mutasa-Gottgens, Matt Hall, Birgit Kerber, Sarah Dayer, Emily Pomeroy, and Laurène Ramos Martins Feeding a growing global population while adapting to challenges posed by climate change remains one of humanity’s most pressing concerns. Worldwide, crops are under threat from […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp